Home  > Gateway Cloning  > 2009 H1N1 Influenza A

2009 H1N1 Influenza A virus Project Status

A checkmark indicates a successful full length clone has been produced and sequence verified.

Click the links for each organism to order

Available Entry Clones

Influenza A Strain

Clone Type

PB2
(1)

PB1
(2)

PA
(3)

HA
(4)

NP
(5)

NA
(6)

M1
(7)

M2
(7)

NS1
(8)

NS2
(8)

Total
clones

A/ New York/ 1682/ 2009 (H1N1)

CDS
with UTR

check

check

check

check

check

check

check

7

CDS

check

check

check

check

check

check

check

check

check

9

Modified
CDS*

check

check

2

A/ New York/ 1669/ 2009 (H1N1)

CDS
with UTR

check

check

check

check

4

CDS

check

check

check

check

check

check

check

7

Modified
CDS*

0

Totals:

29

* The HA and NA CDSs were truncated to omit the transmembrane domains.

Available Expression Clones

Influenza A Strain

Clone Type

Vector

PB2
(1)

PB1
(2)

PA
(3)

HA*
(4)

NP
(5)

NA**
(6)

M1
(7)

M2
(7)

NS1
(8)

NS2
(8)

Total
clones

A/ New York/ 1682/ 2009 (H1N1)

CDS

pIVE- LIC- His_cHalo

check

check

check

check

check

check

6

pFC20A

check

check

check

3

pFC14A

check

check

check

3

A/ New York/ 1669/ 2009 (H1N1)

CDS

pIVE- LIC- His_cHalo

check

1

pFC20A

check

check

check

3

pFC14A

check

check

3

Totals:

18

* The HA CDS was truncated to remove the 3' transmembrane domain and tailing sequence.

** The NA CDS was spliced to remove the 5' transmembrane domain and retain the 5' 18bp leader sequence.

  • The full annotated CDS(s) for each genomic segment has been cloned (stop codons removed) and sequence verified.
  • This table will be updated as more expression clones become verified.

Updated 8/3/09

ABOUT

The PFGRC is making available, at no cost to researchers, sequence validated, cloned open reading frames for use in the study of genes of the novel influenza A (H1N1) virus that was initially detected and identified in April 2009.

The ORFs we have cloned and validated were derived from two clinical isolates A/New York/1669/2009(H1N1) and A/New York/1682/2009(H1N1). We have both Gateway® entry clone constructs available in addition to constructs suitable for direct expression and purification.

CHARACTERISTICS

Gateway® Entry Clones:

  • pDONR221 constructs with standard PFGRC att sites appended to include an N-terminal Not I and a C-terminal Mlu I restriction sites. Gateway entry clone constructs are suitable for shuttling into Gateway® compatible destination vectors via LR cloning reactions.

Expression Clones:

Swine Flu constructs based on the Ligation Independent Cloning (LIC) system.

Each pIVE-LIC-His_cHalo clone construct contains an N-terminal 6x His-tag and a C-terminal Halo tag along with both T7 and SP6 promoters and is suitable for expression and purification either In Vitro or in E. coli cells.

  • N terminal cloning site (5’-3’) GTGCCGCGCGGCAGCCAC
  • C terminal cloning site (5’-3’) AGTGTCGCTCTCGAG

Swine Flu constructs based on Promega’s Flexi® cloning system.

Each open reading frame captured in a pFC20A (Promega catalog #G1681) expression vector contains a C-terminal Halo tag and both T7 and SP6 promoters is suitable for expression and purification either In Vitro or in E. coli cells.

  • N terminal cloning site (5’-3’) CACTATAGAATAAGGAGCGATCGCC
  • C terminal cloning site (5’-3’) GTTTCTCTCGAGCCAACCACTGAGG

Each open reading frame captured in a pFC14A (Promega catalog #G9651) expression vector contains a C-terminal Halo tag suitable for expression and purification in mammalian cells.

  • N terminal cloning site (5’-3’) ACTCACTATAGGGCTAGCGATCGCC
  • C terminal cloning site (5’-3’) GTTTCTCTCGAGCCAACCACTGAGG

Format:

All constructs are harbored in DH10B-T1 E. coli cells and shipped as 15% (v/v) glycerol stocks on dry ice. All available clones are accompanied by a sequence validation report and a brief getting started guide.

Related Links: